CLGN
Collplant Biotechnologies Ltd
Mentions (24Hr)
0.00% Today
Reddit Posts
LIVE: CEI, AVCT, MBOT, PYR, FTFT, CLGN, SPRB, RELI & Other Stocks. Where...
CLGN stock gone up by 35% - nothing major to be found in the news
Mentions
CLGN..Anyone have this stock? They have earnings Wednesday and they look promising. Just bought some.
Hey /u/Normal_Humor2399 - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: IMMR CLGN NCNA. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
Hey /u/Normal_Humor2399 - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: IMMR CLGN NCNA. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
I agree, their data is two weeks behind. You can find these stocks on your own by noting runners of the day then checking to see if they make it onto the reg sho threshold list a few days later. Then keep checking their CTB, even if they aren't on the threshold list. They should be ready for a second run 21 days after the first if CTB is high. This is about the cycle of the FINRA release, if timing is right, one can really hit the ground running. Next fully revised fintel should be evening of 1/11. My bet is that PYR, CLGN, DARE, CALT, RCAT, WEJO are all in the top 20 based on this method. Not financial advice, key word is "bet." This is a casino.
I've got SYTA, I'm with you. You might also want to look at PYR, RDBX, CLGN (all on reg sho threshold list). I'm looking forward to the updated FINRA on 1/11 to see what the real numbers are. I already bought PYR, up 10% today.
I strongly suspect that when the FINRA short report comes out on 1/11 that PYR, DARE, CLGN and RCAT will show as highly shorted. I like these stocks. They all had great news recently and current prices don't reflect the added value. Two are on the REG SHO threshold list. Not financial advice.
Matterport Sea Limited Gingko Bioworks AirBnb CLGN All working on interesting products - some more mature than others.
CLGN is a very interesting play on organ growing.
Thry are public but small CLGN
anyone know whats the deal with CLGN ?
CLGN - betting on fake boobies. Anyone looked into this? They’re commercializing regenerative aesthetic tissue (fake boobies) to make your wife’s boyfriend happy
CollPlant Biotechnologies $CLGN looks interesting. They released financials this morning. Revenues increased by 165% from $2.3 million to $6.1 million. They make collagen based breast implants. Thoughts?
I think cosmetic stuff has great potential. I own CLGN (working on better dermal fillers and breast implants) but will be looking into EOLS too.
Of you like boobs, then check out Collplant (CLGN). They are working on breast implants that could be as good as the real thing. That's part of why I bought shares in it - to invest in boobs!
Yeah, that's how it is for CLGN, MCBC, and MBWM for me. All under 1B but not penny stocks either and they have actual business operations so not many places they can be discussed. Share price shouldn't matter. You could have a 5M market cap with only 5000 shares outstanding, for example.
$CLGN-Today's filing reveals that Q1 of 2021 alone already has at least 14 million in revenue booked, as opposed to 6 million in 2020. It seems that 2021 will be a year in which CLGN actually turns a profit and will be their best year to date. Keep in mind the 14 million is only a partial payment from Allergan and CLGN is entitled to receive up to an additional $89 million in milestone payments. I belive this is what gave recent investors the confidence to invest at 17.50/share for a total invenstment of 35 million dollars. Just under 7 million shares in the float.
Shout out to CLGN coming off the offering super strong
Is this a decent place to ask what you guys think of this stock? CLGN (collplant) All of my knowledge on that company comes from webull. Their financials, their description, institutional holdings, all from webull. I havent seen this on any youtube videos or subreddits yet. I like the stock because it looks like they grew organically based on their charts. Not a stock that jumped up out of nowhere. Couple that with the fact they're an Israeli company, they're a biotech company, the stuff they're doing is not too insane so it seems easier to make money from and pitch to people in medicine, and they did a direct offering. Direct offerings are offerings directly to big investors which shows someone with huge teams of researchers thinks this company has upside potential at a price point of 17.50. Anything around that price should be a good bet with a little time. They were trading up to 24 right before the offering as well which in most cases means they'll be trading at or above that relatively soon.